foxo4-dri senolytic peptide animal study For Sale (10mg) The disordered p53 transactivation domain

Name: foxo4-dri senolytic peptide animal study For Sale (10mg) The disordered p53 transactivation domain
Brand: buntepalette-gmbh.de
SKU: 28185133496
Price: 23.50 USD
Availability: InStock
Rating: 4.505800000000001 (10 reviews)

SKU: 28185133496

4.5

EUR23.50 EUR56.50

Pay in 4 interest-free payments of $5.88 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOX04 DRI Apollo Peptide Sciences FOXO4 DRI (Proxofim) (10mg)

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

& Sakamoto, K

Advances in parathyroid hormone-based medicines

Will it have a significant impact on DHT or E2

Additional screens Endotoxin Janoshik 194144: 3.059 EU/vial Prior batch archive 5mg Batch 1 99.8% Purity Janoshik Analytical Tested March 2026 archive only Research & library Research review Scientific background, literature, and compound context Supplier proof standards How Chameleon documents testing, verification, and research-use safeguards Quality and testing standards How batch records, testing scope, and supporting documentation fit together Research peptide supplier checklist Neutral checklist for reviewing research-material suppliers Scope limit: COAs document analytical testing for research materials